Secondly, using a genetic strategy we showed that NOS2-deficiency significantly enhanced the survival in KPC mouse model of pancreatic cancer, which closely recapitulates the development and progression of human PDAC. This evidence concerns the gene NOS2 and familial pancreatic carcinoma.